The company presented data demonstrating that ADHD patients with mutations in nine genes had a clinically meaningful and statistically significant response to AEVI-001.
These cell subtypes could help researchers gain a clearer understanding of cell mechanics and find better targets for potential therapies.
The companies will build and screen novel DNA-encoded libraries for use by Pfizer in its drug discovery efforts.
The Harvard spinout is commercializing inDrop single-cell sequencing technology developed by Allon Klein.
At the AACR annual meeting, researchers presented results from the Phase II SUMMIT trial investigating the pan-HER-targeted therapy neratinib.
A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.
Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.
Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.
In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.